Log In
Print this Print this

MyoCell SDF-1, SDF-1 modified myoblast (MB) therapy

  Manage Alerts
Collapse Summary General Information
Company U.S. Stem Cell Inc.
DescriptionMyoblasts modified to express stromal derived factor-1 (SDF-1)
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase I
Standard IndicationHeart failure
Indication DetailsTreat congestive heart failure (CHF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today